Linked Life Data

12835898

Source:http://linkedlifedata.com/resource/pubmed/id/12835898

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-7-1
pubmed:abstractText
We have explored the in vitro immunomodulatory effects of pure ruthenium red and a series of pyridine and imidazole substituted ruthenium complexes (RCs).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1023-3830
pubmed:author
pubmed:issnType
Print
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
263-71
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12835898-Animals, pubmed-meshheading:12835898-B-Lymphocytes, pubmed-meshheading:12835898-Cell Division, pubmed-meshheading:12835898-Cell Line, pubmed-meshheading:12835898-Cyclosporine, pubmed-meshheading:12835898-DNA, pubmed-meshheading:12835898-Dogs, pubmed-meshheading:12835898-Fluorescent Antibody Technique, pubmed-meshheading:12835898-G0 Phase, pubmed-meshheading:12835898-G1 Phase, pubmed-meshheading:12835898-Humans, pubmed-meshheading:12835898-Imidazoles, pubmed-meshheading:12835898-Immunity, Cellular, pubmed-meshheading:12835898-Immunosuppressive Agents, pubmed-meshheading:12835898-Interleukin-2, pubmed-meshheading:12835898-Lymphocyte Culture Test, Mixed, pubmed-meshheading:12835898-Pyridines, pubmed-meshheading:12835898-Receptors, Interleukin-2, pubmed-meshheading:12835898-Ruthenium Compounds, pubmed-meshheading:12835898-Ruthenium Red, pubmed-meshheading:12835898-S Phase, pubmed-meshheading:12835898-Sirolimus, pubmed-meshheading:12835898-Superantigens, pubmed-meshheading:12835898-T-Lymphocytes, pubmed-meshheading:12835898-Tetanus Toxoid
pubmed:year
2003
pubmed:articleTitle
In vitro immunomodulatory activity of ruthenium complexes.
pubmed:affiliation
Amgen Inc, One Kendall Square, Cambridge, MA 02139, USA. jnewcomb@amgen.com.
pubmed:publicationType
Journal Article, In Vitro